SHANGHAI, SHANGHAI, CHINA, June 11, 2026 /EINPresswire.com/ — As long-term vascular access therapies continue to expand across oncology, infusion treatment, and ...
The U.S. Food and Drug Administration has issued a Class I recall of Exel/Exelint Huber needles, Exel/Exelint Huber Infusion Sets and Exel/Exelint "Securetouch+" Safety Huber Infusion Sets, ...
NEW YORK, April 30, 2018 /PRNewswire/ -- Persistence Market Research provides key insights and forecast on the global Huber needles market for the forecast period 2017-2024.The primary objective of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results